Moderna Names New CFO After Hasty Departure of Predecessor 
 

James Mock, CFO of PerkinElmer, will join the Covid-19 vaccine maker as finance chief in September.

 
FDA Approves Bluebird's Gene Therapy for Rare Blood Disease 
 

Zynteglo treats patients who rely on regular blood transfusions because of a genetic disease that interferes with the production of hemoglobin.

 
Target's Profit Sinks as Retailer Unloads Unwanted Inventory 
 

Operating margin came in lower than expected after the company discounted items and canceled orders to clear a glut of goods.

 
Hottest Chip Maker Sees Cooling Ahead 
 

Analog Devices' unique business model has spared it from the chip slowdown so far, but its latest results include a warning sign.

 
Amazon Tests TikTok-Like Feed in App 
 

The tech giant is testing a feature in its app that would show users a TikTok-style photo and video feed of products for shoppers to share with other users.

 
Germany's Uniper Reports Heavy Loss Over Russian Gas-Supply Cuts 
 

The country's largest Russian-gas importer posted a net loss of more than $12.6 billion for the first half of the year, hit hard after Moscow slashed deliveries to Germany from June.

 
Elliott Looms Over $16 Billion Philip Morris Deal 
 

Philip Morris might have to raise its bid for Swedish Match to gain full ownership of the smokeless-tobacco maker, in what could prove to be the latest instance of a hedge-fund trade often linked to Elliott.

 
Lowe's Earnings Show Drop in Sales as Do-It-Yourself Customers Spend Less 
 

The home-improvement retailer said it has plans to dole out $55 million in bonuses to front-line workers to help mitigate the pinch they are feeling from rising prices.

 
Crypto Lender Genesis Lays Off 20% of Workforce, CEO to Depart 
 

The moves come after the company was hit hard by the collapse of hedge fund Three Arrows Capital, against which it has a claim of $1.2 billion.

 
Krispy Kreme Stock Is Tumbling. Earnings and Outlook Both Disappointed. 
 

Donut maker Krispy Kreme missed expectations for the second quarter, and cut the year outlook.

 
 

(END) Dow Jones Newswires

August 17, 2022 15:00 ET (19:00 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.